Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2013; 19(43): 7743-7750
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7743
Table 1 Patient characteristics and pathology n (%)
Complicated acute cholecystitis
P valueUncomplicated acute cholecystitis
P value
SILC group (n = 23)3ILC group (n = 27)SILC group (n = 39)3ILC group (n = 19)
Age (yr)51.2 ± 15.358.0 ± 17.30.14749.1 ± 13.954.6 ± 14.50.167
Sex (male/female)7/1610/170.62324/159/100.306
Body mass index (kg/m2)25.24 ± 3.3626.36 ± 3.590.27225.01 ± 2.6726.99 ± 4.350.081
Modified APACHE II score (points)0.3180.595
0-5, low risk21 (91.3)22 (81.5)36 (92.3)17 (89.5)
6-9, intermediate risk2 (8.7)5 (18.5)2 (5.1)2 (10.5)
10-11, high risk001 (2.6)0
Previous abdominal surgery730.089650.319
Previous biliary symptoms12100.28330110.135
Duration of acute symptoms > 72 h14140.52234130.087
Pathology0.985
Gangrene15 (65.2)18 (66.7)--
Empyema6 (26.1)7 (25.9)--
Hydrops2 (8.7)2 (7.4)--
Acute inflammation--39 (100)19 (100)
Table 2 Operative modifications and results n (%)
Complicated acute cholecystitis
P valueUncomplicated acute cholecystitis
P value
SILC group (n = 23)3ILC group (n = 27)SILC group (n = 39)3ILC group (n = 19)
Preoperative ERCP030.099010.148
Preoperative ERCP and EST200.118340.143
Intraoperative cholangiography100.274550.202
Operative time (min)119.8 ± 38.8124.3 ± 32.10.660100.9 ± 42.1118.4 ± 45.50.154
Estimated blood loss (mL)43.2 ± 29.831.0 ± 26.60.15624.2 ± 31.529.5 ± 29.90.548
Pethidine dose (mg/kg)0.624 ± 0.5050.535 ± 0.7400.6320.618 ± 0.4850.549 ± 0.4270.601
Postoperative length of hospital stay (d)3.5 ± 1.14.6 ± 1.3< 0.0102.9 ± 1.13.7 ± 1.4< 0.050
Total length of hospital stay (d)6.0 ± 3.65.8 ± 3.10.8144.1 ± 1.96.4 ± 4.70.053
Conversion
Overall8 (34.8)10 (37.0)0.8697 (17.9)4 (21.1)0.777
2ILC4-3-
3ILC2-1-
4ILC (standard LC)21034
OC0000
Table 3 Postoperative body temperature
Maximum body temperature (°C)Complicated acute cholecystitis
P valueUncomplicated acute cholecystitis
P value
SILC group3ILC groupSILC group3ILC group
Post-op day 137.73 ± 0.5738.03 ± 0.660.09637.41 ± 0.5637.80 ± 0.72< 0.050
Post-op day 237.38 ± 0.5937.58 ± 0.460.18037.10 ± 0.4337.57 ± 0.54< 0.010
Post-op day 337.12 ± 0.4937.30 ± 0.490.21537.04 ± 0.4537.04 ± 0.560.990
Post-op day 437.18 ± 0.4437.19 ± 0.450.97436.88 ± 0.4136.86 ± 0.330.915
Table 4 Complications n (%)
ComplicationsComplicated acute cholecystitis
P valueUncomplicated acute cholecystitis
P value
SILC group (n = 23)3ILC group (n = 27)SILC group (n = 39)3ILC group (n = 19)
Overalll3 (13.0)3 (11.1)0.8343 (7.7)2 (10.5)0.718
Grade I1 (4.3)11 (3.7)22 (5.1)30
Grade II1 (4.3)401 (2.6)51 (5.3)6
Grade IIIa1 (4.3)72 (7.4)800
Grade IIIb0001 (5.3)9
Grade IVa, IVb, V0000
Table 5 Overall comparison of complicated and uncomplicated acute cholecystitis groups
Complicated acute cholecystitis (n = 50)Uncomplicated acute cholecystitis (n = 58)P value
Age (yr)54.9 ± 16.650.9 ± 14.20.184
Sex (male/female)33/1733/250.333
Modified APACHE II score0.320
0-5, low risk43 (86.0)53 (91.4)
6-9, intermediate risk7 (14.0)4 (6.9)
10-11, high risk01 (1.7)
Operative time (min)122.2 ± 35.0106.6 ± 43.6< 0.050
Estimated blood loss (mL)36.1 ± 28.326.0 ± 30.80.092
Pethidine dose (mg/kg)0.577 ± 0.6330.595 ± 0.4640.867
Postoperative length of hospital stay (d)4.1 ± 1.33.2 ± 1.2< 0.001
Total length of hospital stay (d)5.9 ± 3.34.8 ± 3.30.098
Conversion18 (36.0)11 (19.0)< 0.050
Complications6 (12.0)5 (8.6)0.563